Syros Pharmaceuticals, Inc. Quarterly Interest Expense in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Syros Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2019 to Q2 2024.
  • Syros Pharmaceuticals, Inc. Interest Expense for the quarter ending June 30, 2024 was $1.38M, a 8.14% increase year-over-year.
  • Syros Pharmaceuticals, Inc. Interest Expense for the twelve months ending June 30, 2024 was $5.32M, a 13.9% increase year-over-year.
  • Syros Pharmaceuticals, Inc. annual Interest Expense for 2023 was $5.13M, a 24% increase from 2022.
  • Syros Pharmaceuticals, Inc. annual Interest Expense for 2022 was $4.13M, a 5.81% increase from 2021.
  • Syros Pharmaceuticals, Inc. annual Interest Expense for 2021 was $3.91M, a 118% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $5.32M $1.38M +$104K +8.14% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $5.22M $1.31M +$90K +7.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $5.13M $1.33M +$203K +18% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $4.92M $1.3M +$252K +24% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $4.67M $1.28M +$297K +30.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $4.38M $1.22M +$241K +24.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $4.13M $1.13M +$139K +14.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $4M $1.05M +$67K +6.81% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $3.93M $981K +$12K +1.24% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.92M $976K +$9K +0.93% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $3.91M $987K +$446K +82.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $3.46M $984K +$491K +99.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.97M $969K +$482K +99% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $2.49M $967K +$696K +257% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $1.79M $541K +$521K +2605% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-04
Q3 2020 $1.27M $493K +$472K +2248% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $799K $487K +$464K +2017% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $335K $271K +$263K +3288% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $72K $20K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $21K Jul 1, 2019 Sep 30, 2019 10-K 2021-03-04
Q2 2019 $23K Apr 1, 2019 Jun 30, 2019 10-K 2021-03-04
Q1 2019 $8K Jan 1, 2019 Mar 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.